An unusual isolate from a human leg wound was identified as Xenorhabdus luminescens. This finding led to the discovery or isolation of four additional strains, two from blood and two from wounds. Three of the five strains were from patients in San Antonio, Tex. Three strains were studied by DNA-DNA hybridization (SI nuclease-trichloroacetic acid method) and were 77 to 100% related to each other, 34% related to the type strain of X. luminescens, 35 to 40% related to three of Grimont's other DNA hybridization groups of X. luminescens, and 9% related to the type strain of Xenorhabdus nematophilus. The new group of five strains was designated X. luminescens DNA hybridization group 5. All five strains were very inactive biochemically and fermented only D-glucose and D-mannose. The key reactions for recognizing this new organism are yellow pigment production, negative test for nitrate reduction to nitrite, weak bioluminescence (10 to 15 min of dark adaptation is required to see the weak light produced), and a unique hemolytic reaction on sheep blood agar plates incubated at 25°C. Two case histories of strains from wounds are given; these suggest that X. luminescens DNA hybridization group 5 may be a new bacterial agent that causes wound infections. The two cases of wound infection, along with the two blood isolates, suggest that the new organism is clinically significant.
tered in human clinical specimens. Until now, the genus Xenorhabdiis was thought to be an insect pathogen and a colonizer of nematodes (28) but not humans.
In 1965 Poinar and Thomas described Achroinobacter nematophilus, a new bacterial species isolated from the intestinal lumen of a nematode (23) . Subsequently, these authors noted that this organism did not fit well into a redefined genus Achromobacter, and they proposed Xenorhabdus as a new genus in the family Enterobacteriaceae (30) . Xenorhabdus has two species, X. nemcatophilus (formerly Achromobacter nematophilus) and X. luminescens (3, 8, 30, 31) . X. luminescens is very unusual because it is bioluminescent, a trait not found in any other species of the family Enterobacteriaceae (30) .
Over two dozen papers on the genus Xenorhabduis have been published (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) , and these organisms are well known as bacteria found in nematodes and as insect pathogens. In 1985 Farmer et al. (9) summarized their experience with the new species of Enterobacteriaceae and stated that Xenorhabduis was found in nematodes, but "'should be of little concern for the clinical microbiologist, since they have never been isolated from a clinical specimen." However, in 1986 one of us (J.H.J.) isolated strain 1 ( finding led to identification of additional strains from human clinical specimens and is the subject of this report.
MATERIALS AND METHODS Scope of study. Originally this paper was to be a case report on a single isolate of X. lIuninescens (strain 1 in Table  1 ). Thus, this strain was studied in more detail than the others, which were found much later.
Nomenclature. Although the genus Xenorhabdus has only two named species, each has been subdivided. Four subspecies names have been proposed in X. neinatophilus (3, 4) , and four DNA hybridization groups were found by Grimont et al. (10) in a small collection of X. luminescens strains. Our clinical isolates of X. luininescens represent a fifth DNA hybridization group (Table 1) .
Laboratories. Six laboratories studied strain 1 and did various phenotypic tests, pathogenicity assays, and nematode association tests. We numbered the laboratories (to facilitate discussion of results) in the order in which they studied the strain: laboratory 1, University of Texas Health Science Center at San Antonio and Medical Center Hospital; laboratory 2, Texas Department of Health; laboratory 3, Enteric Bacteriology Section, Centers for Disease Control (CDC); laboratory 4, University of California, Berkeley; laboratory 5, Commonwealth Scientific and Industrial Research Organisation, Canberra, Australia; and laboratory 6 work with human clinical isolates, and their methods are well known to clinical microbiologists (9) . Laboratories 4 and 5 work with Xenorhabdus spp., insect larvae, and nematodes, and their methods have been described in detail (3, 30) .
Biochemical reactions. Biochemical reactions were studied in each of the six laboratories. Laboratories 1, 2, 3, and 6 used an incubation temperature of 35 to 37°C and standard biochemical testing methods (9) . Laboratory 4 used different methods, and incubation was at 30°C (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Laboratory 5 used different methods. and incubation was at 28°C (1) (2) (3) (4) Bioluminescence. Laboratories 5 and 6 measured light emissions in a scintillation counter (10) . In laboratory 3 bioluminescence was detected with two methods, as follows. In method 1, the growth on a blood agar plate was observed in a darkroom (total darkness) for luminescence. A 5-min period was used for the observer's eyes to adjust to the dark. Any light seen was considered positive. In method 2 (begun in 1988), a Packard 2450 scintillation counter was used to measure light emission. Growth from a 24-h-old blood agar plate was removed (about 1.5-cm-diameter circle) with a swab, and a heavy suspension was made in 5 ml of sterile distilled water. The suspension was transferred to a 20-ml scintillation vial and was counted for 1 min with a fully opened window setting. Two negative controls were also counted: water and an Escherichia coli suspension.
Growth on MacConkey agar. A suspension of each organism was made in heart infusion broth (approximately 10' organisms per ml), and 0.01 ml of each was plated on MacConkey agar (Difco Laboratories, Detroit, Mich.) and blood agar plates. These plates were incubated at 36°C and observed at days 1, 2, 3 or 4 or 5, and 7. Pathogenicity for insect larvae and nematode association.
Pathogenicity for larvae (3, 20) of the wax moth (Galleria mellonella) was determined for strain 1 in laboratories 4 and 5 by injecting between 50 and 5,000 bacterial cells into the larvae. Laboratory 4 used 15 larvae each for doses of 50, 500, and 5,000 cells (20) . Laboratory 5 used a similar technique (3) . The association of strain 1 with a Heterorhabditis nematode was tested in laboratory 4 by adding the bacterium to sterilized eggs of the nematode (15) . This was done because the original strains of X. luiminescens formed a strong association with Heterorhabditis nematodes. The occurrence of strain 1 in the primary or secondary phase was tested in laboratories 4 and 5 by absorption of bromothymol blue and neutral red and by the presence of antibiotic activity (4, 30) . DNA-DNA hybridization (laboratory 6). Laboratory 6 did DNA-DNA hybridization as follows. Strain 1 was labeled in vitro with tritium-labeled nucleotides, and hybridization was done by the SI nuclease-trichloroacetic acid method (10) . The strains tested are given in Table 1 .
Search for additional strains of X. luminescens from human clinical specimens. The computer program Strain Matcher (9) was used to locate strains sent to CDC that are biochemically similar to strain 1. Since X. luininescens strains are very inactive biochemically, the Special Bacteriology Laboratory at CDC tested strain 1 by their methods and VOL. 27 His physical examination and laboratory test results included blood pressure of 150/92, pulse of 90, and a temperature of 98.6°F (ca. 37°C). He had small, firm, tender, matted lymph nodes in his left groin and an ulcer (2 by 2 cm) below the left knee with surrounding erythema and a small amount of fluctuance. Erythema and induration were noted in the left thigh in a linear distribution. His leukocyte count was 9,400/ml, with 70% polymorphonuclear leukocytes, 1% band forms, 23% lymphocytes, 4% atypical lymphocytes, and a hematocrit of 41.3%. His electrolytes, erythrocyte sedimentation rate, and liver enzymes were within normal limits. X rays of the left thigh and knee indicated no evidence of osteomyelitis. Three blood cultures drawn before antibiotic therapy were negative, as was a urine culture from admission. A swab of his ulcer yielded light growth of Staphylococcus aureus and light growth of a gram-negative, lactosenegative rod. This gram-negative rod was not further characterized before the patient was discharged, but was susceptible to chloramphenicol, tetracycline, gentamicin, and cefoxitin and resistant to cephalothin and ampicillin. An aspirate of the indurated area of the left thigh, obtained in the emergency room, grew the same lactose-negative, gramnegative rod in pure culture. Two days after admission, the thigh was again aspirated and grew the same gram-negative rod in very light growth. A sonogram of the thigh was negative. The patient was treated with intraveneous cefoxitin (2 g every 6 h) and oxacillin (2 g every 4 h) for 10 days, during which the area of induration resolved and the pretibial ulcer decreased in size. The patient was then followed up as an outpatient, and all symptoms and signs of infection resolved.
Since the gram-negative rod could not be identified with certainty, it was forwarded to the Texas Department of Health, where it was suspected to be Xenorhabdus sp. The isolate was further studied at laboratories 3 (30) . These have been referred to as the primary and secondary phases (23, 25, 30 One week after admission the patient was returned to the operating room, where a localized purulent pocket was drained (but not cultured) and a split-thickness skin graft was placed over the contiguous debrided areas on the left lower extremity. He was given cefoxitin (1 g every 6 h) intravenously for 3 days after surgery. He did well after surgery and was discharged 16 days after admission. He has subsequently had an uneventful recovery during followup in surgery clinic. Strain 4 was identified as a typical strain of X. luimiinescens in laboratories 1, 2, and 3 ( Table 2 ).
DNA-DNA hybridization. Table 1 gives the results of the hybridization experiments done in laboratory 6. Strain 1 was radioactively labeled and tested against strains 1, 2, and 3 (strains 4 and 5 had not been detected at this time). All three strains were highly related, and strain 3, which had the lowest value (77%), had a low àT,, value. Eight other strains of X. lininescens, representing all four DNA hybridization groups previously described by Grimont et al. (10) , were only 34 to 40%, related to strain 1, with AT,,, values of over 16 . The type strain of X. nencatophilus was only 9Y% related.
Biochemical characterization of ail five strains of X. luminescens DNA hybridization group 5. Table 2 gives the biochemical characteristics of the five strains in media often used in clinical microbiology laboratories for biochemical characterization. At 36°C the strains were very inactive and had a pattern quite distinct from any other species or biogroup of Enterobacteriaceae.
Yellow pigment. Four of the five strains produced a yellow pigment on TSA at 36°C within 2 days. At 25°C they took 2 to 5 days. Strain 1216-79 was not yellow, but produced a tan soluble pigment on TSA after 3 to 5 days (36°C). Two strains, 3107-77 and 2617-87, produced weak yellow pigment in 1 day, but were bright yellow in 2 days and were also bright yellow in TSA working stocks.
Hemolysis on sheep blood. At 36°C, the strains had alpha hemolysis within 2 days, but by 3 to 5 days they had lysis and greening. At 25°C all five strains had a unique type of hemolysis (Fig. 1) . It started as a tiny line of beta hemolysis some distance from the colony itself (approximately 13 mm). Eventually this line of hemolysis encircled all the growth, but did not extend up to the colonies. Four strains had this unique type of hemolysis by day 2, but strain 3 required 3 to 5 days. This type of hemolysis was not observed when strains were grown at 36°C for 7 days or when grown at 36°C for 2 days and then transferred to 25°C for the remaining 5 days.
Bioluminescence. AIl of the strains were luminescent by both methods. When the blood plates were observed in the darkroom, all of the strains appeared luminescent within 6 min. This extremely weak luminescence is in contrast to most luminescent strains of Vihrio spp., which are visible within a few seconds. Strain 5 was the weakest of the strains. In the scintillation counter the strains produced various amounts of light. Although strain 5 was weak when observed in the darkroom, it had the highest count in the scintillation VOL. 27, 1989 on July 11, 2017 by guest http://jcm.asm.org/ Downloaded from 100 100 100
counter. Although strain 4 had the lowest count, it appeared as strong as the others in the darkroom (strain 4, 90,000 cpm; strain 2, 660,000 cpm; strain 3, 1,500,000 cpm; strain 1, 1,700,000 cpm; strain 5, 1,900,000 cpm; E. coli, 13 cpm; distilled water, 9 cpm). Strain 3 needed 2 days to produce sufficient growth for testing. Growth on MacConkey agar. All of the strains grew on MacConkey agar within 2 days; however, the plating efficiency was slightly reduced (no growth on the last quadrant of streaking as opposed to growth on blood agar). The colonies were colorless (lactose negative) and measured 0.5 to 4.0 mm in diameter.
Morphology on blood agar. The strains grew well on blood agar and preferred 36°C to 25°C. After 2 days of incubation most of the colonies were 1 to 4 mm in diameter, but some were smaller. All of the strains had two colony types (the second was smaller), but biochemical reactions on both types were the same. The colonies were smooth and entire. The two strains previously described that produced a strong yellow pigment were also yellow on blood agar, but it was difficult to see the pigment of the other three strains. When Gram stains were done with 1-day-old growth from blood agar plates (36°C), the cells appeared as short-to-medium gram-negative rods with occasional filaments, granules, and bipolar staining. Antibiotic susceptibility. All five strains had large zones around each of the antibiotics except penicillin G, ampicillin, carbenicillin, and cephalothin (Table 3 ).
DISCUSSION
Xenorhabdiîs was described as a new genus in 1979 (30) . It has been studied thoroughly because both X. nematophilus and X. luminescens are insect pathogens and are used in insect pest control. As more strains have been studied, the nomenclature and classification of the genus have become more complex (3, 4, 10, 31) . Akhurst divided X. nematophilus into four subspecies, each of which was given a formal name (3, 4) . Grimont et al. studied a small collection of X. luminescens strains and found four distinct DNA hybridization groups (10) . No scientific names were given, but all four groups could be considered to be distinct species. However, until now the genus Xenorhabdus has been of little concern to the clinical microbiologist.
In this paper we describe a bioluminescent organism that occurs in clinical specimens and appears to be clinically significant. The organism most resembles X. luminescens by both phenotypic characteristics and DNA hybridization. We refer to this new organism as X. luminescens DNA hybridization group 5, since it is not highly related to the previously described four DNA groups. In the future it will probably be given a scientific name. The luminescent strains of the genus Xenorhabdiis are quite distinct from the nonluminescent currently no information suggesting that strains of X. Iliinnines(ens DNA groups 1 through 4 have occurred in human clinical specimens; however, this point deserves further study.
The biochemical inactivity of X. lumninies( en s may cause problems for recognition and identification in clinical laboratories. The strains listed in Table 1 could be confused with a number of different species of Enter-obac(teriac eae, particularly those that contain strains that are very inactive biochemically. However, a number of distinct properties should make it possible to recognize and identify cultures of X. Ilinines(cenis. The unusual hemolytic reaction, yellow pigment, and negative test for nitrate reduction should be helpful markers, but bioluminescence is the single characteristic that quickly defines this organism. Weak bioluminescence is easily detected in a scintillation counter, but is more difficult to detect with dark-adapted eyes. Laboratory 3 did not detect the bioluminescence of strain 1 even though this laboratory works with bioluminescent vibrios and Xeno1-habdits and used 5 min of dark adaptation before calling it negative. Cultures from clinical specimens suspected to be X. luwninesce ns should be watched in a totally dark room from 10 to 15 min or tested in an instrument. The biochemical reaction pattern given in Table 2 should be helpful in recognizing strains. Table 4 gives the tests that differentiate X. luininescens from X. neinatophillus and other members of the family Enterobaccteriac ea. We hope this report will stimulate other clinical and public health laboratories to isolate and identify this unusual organism and help define its role in human disease. Our laboratories are interested in infections that yield this organism and would be grateful for information about additional cases. ACKNOWLEDGMENT We thank Dannie G. Hollis of the Special Bacteriology Laboratory, CDC. for searching their laboratory's collection for possible isolates of X. luzinnescens.
ADDENDUM IN PROOF
We recently studied a sixth isolate of X. lunines(ens. It was from a groin infection of a patient at a different hospital in San Antonio, Tex.
The genus Xenorhlabduis is becoming more complex. Akhurst and Boemare (R. J. Akhurst and N. E. Boemare, J. Gen. Microbiol. 134:1835 Microbiol. 134: -1845 Microbiol. 134: , 1988 ) recently proposed that the subspecies of X. neinatophilus be elevated to species. In this classification there are five species of Xenorhiahdus: X.
VOL. 27, 1989 on July 11, 2017 by guest http://jcm.asm.org/ Downloaded from neinatophilus, X. beddingii, X. bo'ieflii, X. poinarii, and X. lumninescens (including five DNA subgroups).
